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California San Diego, San Diego, CA, USA.
Abstract
Objectives—The aim of this study was to determine if early gadolinium enhancement (EGE) by 
cardiovascular magnetic resonance (CMR) imaging in a canine model of reperfused myocardial 
infarction depicts the area at risk (AAR) as determined by microsphere blood flow analysis.
Background—It remains controversial whether only the irreversibly injured myocardium 
enhances when performing CMR imaging in the setting of acute myocardial infarction. Recently, 
EGE has been proposed as a measure of the AAR in acute myocardial infarction as it correlates 
well with T2-weighted imaging of the AAR, but still requires pathological validation.
Methods—Eleven dogs underwent 2 hours of coronary artery occlusion and 48 hours of 
reperfusion prior to imaging at 1.5T. EGE imaging was performed 3 minutes after contrast 
administration with coverage of the entire left ventricle. Late gadolinium enhancement (LGE) 
imaging was performed between 10 and 15 minutes after contrast injection. AAR was defined as 
myocardium with blood flow (mL/min/g) <2SD from remote myocardium determined by 
microspheres during occlusion. The size of infarction was determined using triphenyltetrazolium 
chloride (TTC).
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Results—There was no significant difference in the size of enhancement by EGE compared to 
the size of AAR by microspheres (44.1± 15.8% vs. 42.7± 9.2%, p=0.61) with good correlation 
(r=0.88, p <0.001) and good agreement by Bland-Altman analysis (mean bias 1.4± 17.4%). There 
was no difference in the size of enhancement by EGE compared to enhancement on native T1 and 
T2 maps. The size of EGE was significantly greater than the infarct by TTC, (44.1± 15.8% vs. 
20.7± 14.4%, p<0.001) and LGE (44.1± 15.8% vs. 23.5± 12.7%, p<0.001).
Conclusion—At three minutes post-contrast, EGE correlated well with the AAR by 
microspheres and CMR, and was greater than infarct size. Thus, EGE enhances both reversibly 
and irreversibly injured myocardium.
Keywords
Gadolinium enhancement; Area at risk; Acute myocardial infarction; Cardiovascular Magnetic 
Resonance Imaging
Introduction
Cardiovascular magnetic resonance (CMR) imaging with late gadolinium enhancement 
(LGE) is widely used in the determination of size and extent of myocardial infarction (1). 
However, it remains controversial whether gadolinium enhanced CMR only depicts infarcted 
tissue. Recently, two reports presented data in which early gadolinium enhancement(EGE) 
correlated well with T2-weighted images as a marker of area at risk(AAR) in a clinical 
setting (2,3). These findings are intriguing, and supported by previous work that found 
overestimation of infarct size by gadolinium enhanced imaging (4-6). To further validate the 
correlation between EGE and AAR, comparison of EGE to a pathological reference standard 
for the AAR is necessary. Furthermore, the previous studies of the correlations between 
EGE and T2-weighted AAR assessment were performed on a single slice per patient. How 
well EGE performs on a whole heart basis has yet to be determined.
The aim of this study was to examine the relationship between the size of EGE and 
pathological standards of AAR and infarct size using a phase sensitive inversion 
recovery(PSIR) sequence that images the entire left ventricle minutes after contrast 
administration in a canine model of acute myocardial infarction. How well the size of EGE 
compared to CMR measures of the AAR (quantitative native T1 and T2 maps) was also 
determined, as these modalities have shown good correlation to the pathological AAR (7).
Methods
Animal model
Mongrel dogs weighing 15-20kg were studied after approval by the Animal Care and Use 
Committee of the National Heart, Lung and Blood Institute of the National Institutes of 
Health. Animals were pretreated with amiodarone(6mg/kg/day) for one week to minimize 
arrhythmia during ischemia. Anesthesia was induced with a mixture of intramuscular 
0.4mg/kg midazolam and 0.1mg/kg hydromorphone, followed by intravenous propofol 
(2-6mg/kg). General anesthesia was maintained during surgery after intubation with 2-5% 
inhaled sevoflurane. Intravenous and arterial lines were established, as well as a permanent 
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left atrial catheter for administration of microspheres. After thoracotomy at the left fifth or 
sixth intercostal space, the left anterior descending artery was isolated and a snare placed 
distal to the first diagonal branch. Collateral vessels were not tied off. During occlusion, 
approximately 5×106 fluorescent microspheres (IMT Laboratories, Irvine, CA, USA) were 
administrated with simultaneous reference blood sampling from an arterial line. The snare 
was released after 120 minutes of occlusion. After surgery, the animals were monitored and 
treated for pain control and hemodynamic stability by trained animal care personnel for 48 
hours prior to CMR imaging. Animals were anesthetized prior to imaging as previously 
described. Immediately before CMR, 5×106 fluorescent microspheres of a different color 
were administrated to assess the quality of reperfusion. All animals were euthanized upon 
completion of imaging with an overdose of potassium chloride under general anesthesia.
CMR imaging
Imaging was performed on a 1.5T clinical scanner (Magnetom Avanto, Siemens Healthcare 
Sector, Erlangen, Germany) with an eight-channel phased array coil. Quantitative native T1 
mapping was performed with a motion corrected Modified Look- Locker Inversion-
Recovery sequence with image acquisition 5 seconds after the first inversion followed by a 3 
second pause and 3 seconds of acquisition after the second inversion, and steady state free 
procession readout. The following typical imaging parameters were used: field of view: 
280×154mm2, matrix: 192×80, slice thickness: 6mm, voxel size 1.9×1.5×6mm3 = 17μL/
voxel, repetition time: 2.6ms, echo time 1.1ms, parallel imaging factor 2. Quantitative native 
T2 mapping was performed using a fast low angle shot readout sequence and T2 
preparations at 5, 40, and 80ms. Typical parameters were: field of view: 280×154mm2, 
matrix: 192×80, slice thickness: 6mm, voxel size 1.9×1.5×6 mm3, repetition time 4ms, echo 
time 1.6ms, parallel imaging factor 2.
EGE imaging was performed three minutes after administration of a 0.2mmol/kg 
intravenous bolus of contrast (gadopentetate dimeglumine, Magnevist®, Bayer Healthcare 
Pharmaceuticals, Wayne, New Jersey). To achieve whole heart coverage at this time point, 
images were acquired every other heart beat with an ECG triggered, breath-held, PSIR 
single shot sequence and steady state free procession readout. Nine slices were obtained in 
18 heart beats. Typical parameters were: field of view: 280mm×154mm, matrix: 192×80, 
voxel size 1.9×1.5×6 mm3, 50° flip angle, repetition time: 3ms, echo time: 1.5ms, parallel 
imaging factor 2, and inversion time 200ms.
Standard LGE images were acquired >10 minutes after contrast injection using an ECG 
gated, segmented, PSIR fast low angle shot readout sequence (8) with the following typical 
parameters: field of view 280mm×156mm, matrix 256×108, voxel size 1.5×1.1× 6mm3, 10 
μL/voxel, 25° flip angle, repetition time: 8.5ms, echo time: 3.3ms, parallel imaging factor 2. 
The inversion time was manually adjusted to null normal myocardium.
Pathology and microsphere analysis
After explantation, hearts were set in 2% agarose gel and sliced on a commercial meat slicer 
in 3 mm thick slices and stained with 1% triphenyltetrazolium chloride(TTC) for infarct 
demarcation and subsequently photographed. TTC images were matched to CMR images 
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using landmarks such as papillary muscles and the right ventricular insertion point blinded 
to the microsphere blood flow results. For whole heart coverage, a basal TTC slice and 
apical TTC slice were matched to corresponding CMR images, and all slices in that range 
were included in the analysis. The borders of endocardium, epicardium and non-stained 
areas were manually delineated to determine infarct size as a percentage of the left ventricle. 
Additionally, a slice-by-slice comparison of the AAR by microspheres and by EGE was 
done. In this comparison, only the slices that could be matched to an image were included. A 
representative example is depicted in Figure 1.
Two consecutive TTC slices were combined for further transmural sectioning and 
microsphere analysis to achieve the same slice thickness as the CMR images. The 
myocardium of the left ventricle was sectioned into transmural radial sectors. Sectors in the 
infarcted area (defined by TTC) were further sectioned into an endocardial and epicardial 
section. This was done to account for the great deal of collateral circulation in dogs, which 
could result in residual blood flow (during occlusion) epicardial to the infarcted area. Doing 
this minimized partial volume effects. A few sectors of normal myocardium were also split 
into endocardial and epicardial subsections. Each myocardial sector weighed approximately 
0.7g, to ensure a sufficient number of microspheres per sector for reliable analysis. Tissue 
samples were sent to an external laboratory for myocardial blood flow determination (IMT 
Laboratories, Irvine, CA, USA). Myocardial sectors with blood flow <2SD below blood 
flow in remote myocardium were defined as AAR. The summed weight of AAR sectors was 
divided by the total left ventricle mass.
Image analysis
Image analysis was performed using a custom in-house software program. Endocardial and 
epicardial borders were manually delineated. Hyperenhancement on EGE images, as well as 
native T1 and T2 maps, was defined as pixels with signal intensities >2SD from remote 
myocardium for semiautomatic quantification. Spurious, non–contiguous pixels were 
excluded. Hypoenhanced pixels within an area of hyperenhancement (regions of 
microvascular obstruction or hemorrhage) were included as infarcted pixels in the 
hyperenhanced area.
On LGE images, infarct was defined as areas of enhancement based on the feature analysis 
and combined thresholding computer algorithm, which has previously been validated by 
pathology (9). Enhancement on CMR images was presented as a percentage of the entire left 
ventricular myocardium. Whole heart coverage was used to minimize partial volume effects, 
potential mis-registration and ex vivo shrinking of the myocardium for comparisons to 
pathological infarct sizing by TTC.
Statistical analysis
Statistical analysis was performed using MedCalc (version 12.7.7, Ostend, Belgium). 
Normally distributed data is presented as mean± SD, non-normally distributed data is 
presented with medians and interquartile ranges(IQR). After confirmation of normality, 
paired t-tests were performed to compare means. The Wilcoxon signed-rank test was used 
for non-parametric data. Correlations were assessed using Pearson’s correlation coefficient r 
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for normally distributed data, and Spearman’s rank correlation in other cases. Limits of 
agreement were performed with Bland-Altman analysis and presented as mean difference 
± 2SD. Based on an a priori sample size calculation, a minimum of 10 experiments were 
required to detect a correlation of 0.9 between AAR at risk by EGE and microspheres with a 
power of 0.9 and alpha 0.01.
Results
Eleven animals underwent successful coronary artery occlusion and reperfusion before CMR 
imaging (Figure 1). Microsphere data was available for all animals (n=11) at occlusion. On 
average, the left ventricle of each animal was sliced into 91 sectors (range 66-131). 
Microsphere data was only available for nine animals 48 hours after reperfusion due to 
inadequate reference blood flow sampling. During vessel occlusion, blood flow in the AAR 
was significantly lower than remote myocardium, 0.177± 0.043 ml/min/g vs. 0.579± 0.17 
ml/min/g, p<0.001. In the ischemic core, the myocardial blood flow during occlusion was 
9.4% (IQR, 6.2%-8.7%) of the blood flow in remote myocardium. The myocardial sectors 
identified as infarcted by TTC during slicing had significantly lower blood flow than the 
epicardial sectors that were part of the AAR (0.067 ml/min/g (IQR 0.034-0.17 ml/min/g) vs. 
0.16 ml/min/g (IQR 0.097-0.28 ml/min/g) p<0.001). The transmural gradient in the 
subdivided remote myocardial sectors was not statistically significant (remote endocardium 
0.60± 0.20 ml/min/g vs. remote epicardium 0.57± 0.17 ml/min/g, p=0.25)
At the time of CMR imaging, there was no difference in the blood flow in the AAR as 
compared to remote (0.34± 0.21 ml/min/g vs. 0.31± 0.18ml/min/g, p=0.17), or in the 
ischemic core compared to remote (0.29± 0.20 ml/min/g vs. 0.31± 0.18 ml/min/g, p=0.58) 
indicating successful reperfusion. The size of the AAR by microspheres was greater than the 
size of infarct by TTC in all animals (42.7± 9.2% vs. 20.7± 14.4%, p<0.001) indicating 
significant salvage.
Early Gadolinium Enhancement for Area at Risk Assessment by Microsphere Analysis
There was no significant difference in the size of enhancement on EGE images compared to 
the size of perfusion defect by microspheres (44.1± 15.8% vs. 42.7± 9.2%, p=0.61, Figure 
2). The size of EGE correlated well to the size of the AAR by microspheres (r=0.88, 
p<0.001, Figure 3). Bland-Altman analysis revealed good agreement, with a mean bias of 
1.4± 17.4% of the entire left ventricle, Figure 3. In a per slice comparison, the size of 
enhancement on EGE also correlated well with the microsphere AAR (r=0.89, p<0.001,), 
Figure 4..
Early Gadolinium Enhancement for Area at Risk Assessment by Quantitative Maps
Compared to CMR measures of AAR (native T1 and T2 map data was available in 10 
studies), there was no significant difference in the size of enhancement by EGE compared to 
the size of enhancement on native T1 maps (45.8± 15.6% vs 43.4± 16.1%, p=0.06). The 
correlation between EGE and T1 maps was excellent (r=0.98, p<0.001, with a mean bias of 
2.4%± 6.9%. Similarly, there was no significant difference between the enhancement by 
EGE and native T2 maps (44.2± 16.7% vs. 39.0± 16.2%, p=0.11). There was good 
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correlation (r=0.85, p<0.01,) between EGE and enhancement on T2 maps, with a slight 
overestimation by Bland-Altman analysis (5.2± 17.8%). The comparison of the size of EGE 
to the size of AAR defined by CMR measures is presented in Figure 5. The size of the AAR 
by both types of quantitative maps did not show any difference compared to the size of the 
AAR by microsphere analysis: 43.4± 16.1% vs. 43.2± 9.6%, p=0.95 for T1 maps vs. 
microspheres and 39.0± 16.2% vs. 43.2± 9.6%, p=0.27 for T2 maps vs. microspheres.
Early Gadolinium Enhancement and Measures of Infarction
Three representative studies are depicted in Figure 6, where the EGE exceeds the infarction 
by LGE and TTC. In all animals, the size of enhancement by EGE was greater than the size 
of infarction by TTC, Figure 1 and 7. The size of EGE was significantly greater than the 
infarct by TTC, 44.1± 15.8% vs. 20.7± 14.4%, p<0.001). This was also the case for the size 
of enhancement by EGE compared to that of LGE (44.1± 15.8% vs. 23.5± 12.7%, p<0.001). 
Also, LGE showed excellent correlation to infarct size by TTC (r=0.95, p<0.001) and only 
very small systematic bias), see Figure 8.
Discussion
This study demonstrates that the AAR can be determined by EGE, as there is a good 
correlation between the size of EGE by CMR and the size of the AAR as determined by 
microspheres, the pathological reference standard. There was also a very good correlation 
between the size of hyperenhancement by EGE and other CMR measures of AAR in this 
study: native T1 and T2 maps. Furthermore, the size of gadolinium enhancement three 
minutes after contrast administration was clearly greater than the pathological standard of 
infarct size in this canine model of reperfused acute myocardial infarction. LGE correlates 
much more closely with infarct size. Also, a method is presented that can image early 
gadolinium enhancement of the entire left ventricle in about 18 heartbeats. Combining early 
and late gadolinium enhancement enabled evaluation of AAR and infarct size for the whole 
heart as Matsumoto et al previously suggested (2). An independent pathological standard of 
microspheres and TTC confirms this finding.
While the correlation between AAR by T2-weighted imaging and EGE has been 
demonstrated in recent clinical studies (2,3), previous preclinical studies have also reported a 
close correlation between gadolinium enhancement and the AAR by pathological standards 
(6,10). The findings in this study support the hypothesis of possible overestimation of infarct 
size by gadolinium enhancement in acute myocardial infarction, which has been reported by 
numerous authors throughout the years (4,5,11). The use of PSIR sequences mitigates the 
difficulties associated with choosing correct TI times, reducing the bias that may be due to 
imaging parameters and addressing technical variables that may have contributed to the 
disparate findings. Overestimation of infarct size by gadolinium enhancement was recently 
confirmed in a porcine study by Jablonowski et al using a PSIR sequence (12).
Contrast enhanced cine steady state free precession images have also been reported to 
correspond to the AAR both determined by SPECT and T2-weighted imaging in patients 
(13,14). While this technique relies on both the T1 and T2 properties of the myocardium, it 
has been proposed that part of the bright signal may be a result of the T1 shortening 
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properties of gadolinium in the salvaged myocardium and not only in the infarct. 
Additionally, clinical studies have found functional recovery in areas of myocardium that 
display gadolinium enhancement, as well as reduction in the extent of enhancement in the 
following weeks to months, indicating also that irreversibly injured myocardium shows 
dynamic gadolinium enhancement(15-18).
Arheden et al demonstrated in rats that the distributional volume of gadolinium contrast was 
greater in myocardium that had undergone 20 minutes of ischemia, but did not display 
infarction by TTC when compared to normal myocardium, although it was less than that of 
infarcted myocardium (19). Recently published data also showed that the salvaged 
myocardium in a porcine model of ischemia and reperfusion had an increased ECV 
compared to normal myocardium both one day and seven days after ischemia (12). This 
provides a basis for the understanding of accumulation of gadolinium, an extracellular 
contrast agent, not only in the irreversibly damaged myocardium, but also in reversibly 
damaged myocardium. The expansion of the extracellular space and interstitial edema as a 
response to ischemia in reversibly injured myocardium, in addition to intracellular edema, 
has been reported previously in pathoanatomical studies (19-21). Expansion of the ECV in 
reversibly injured myocardium may be a result of several features of ischemic injury: shifts 
in electrolytes from the intracellular to the extracellular space, increased microvascular 
permeability resulting in protein leakage from the intravascular compartment, and structural 
alterations in the extracellular matrix (21-25). Conversely, the greater ECV in irreversibly 
injured myocardium is also due to loss of membrane integrity in the injured cells and passive 
diffusion of gadolinium into the intracellular space (26), why this ECV is greater than in the 
normal and reversibly injured myocardium. Klein et al showed different wash-in/washout 
kinetics in infarcted and remote myocardium in a clinical study (27). Differences in contrast 
kinetics must also be important in reversibly damaged myocardium, as enhancement of the 
salvaged myocardium is not as pronounced in LGE acquisitions. The findings in this study 
therefore support the current literature and adds important new insight into the concept that 
gadolinium not only depicts irreversibly injured myocardium, but also transiently enhances 
reversibly injured myocardium.
While EGE for determination of the myocardial AAR is exciting, and easily interleaved in 
the clinical workflow, more work is necessary to unveil its clinical usefulness. It remains to 
be determined how long after a myocardial infarction this technique can reliably be applied. 
In a canine model, a substantial decrease of T2 values in the salvaged myocardium (and thus 
edema) was evident within the first 48 hours after infarction (28), and a recent porcine study 
suggests a bimodal pattern of edema within the first days of reperfusion (29). These may be 
species specific effects as the size of AAR by T2-weighted imaging in clinical studies has 
been shown to be stable within the first 7 days (30). Furthermore, the optimal timing for 
EGE image acquisition after contrast administration requires further elucidation. In patients 
imaged up to 5 days after acute myocardial infarction, Matsumoto et al found the optimal 
timing for demarcation of EGE to be 2 minutes after contrast administration, when 
compared to T2 weighted enhancement as an indicator of the AAR(3).
This preclinical validation study has some limitations. A canine model of reperfused 
infarction, may exhibit different contrast kinetics compared to humans. Animals were 
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imaged only once after 48 hours of reperfusion. Studying EGE after varying durations of 
reperfusion is necessary in order to understand the dynamic processes involved in the 
regression of edema and the effect this has on the accuracy of EGE in quantifying the AAR. 
The AAR by EGE (or other CMR measures) may have a higher signal intensity compared to 
the remote in animals scanned after only a few hours of reperfusion, and thus a higher 
contrast-to-noise ratio compared to after 2 days, assuming that some of the initial expansion 
of the ECV resolves by 2 days of reperfusion. Additionally, this study was performed in a 
tightly controlled setting with healthy animals. The influence of factors such as 
preconditioning, varying amounts of collateral flow, adequacy of reperfusion, and 
differences in contrast elimination may have an influence on the these findings in the clinical 
setting.
In conclusion, EGE correlates well with the size of the AAR and thus enhances both 
reversibly and irreversibly injured myocardium. LGE accurately images myocardial 
infarction in the same animals.
Acknowledgments
The authors thank Katherine Lucas for animal care and technical support.
Funding
This work was supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute, 
National Institutes of Health, USA [Z01 HL006136-04 and HL004607-16]. Dr. Arai is a principal investigator on a 
US government Cooperative Research and Development Agreement (CRADA) with Siemens Medical Solutions 
(HL-CR-05-010).
Abbreviations
AAR area at risk
CMR cardiovascular magnetic resonance
ECG electrocardiography
EGE early gadolinium enhancement
IQR inter quartile range
LGE late gadolinium enhancement
PSIR phase sensitive inversion recovery
ROI region of interest
SD standard deviation
TTC triphenyltetrazolium chloride
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Perspectives
Competency in Medical Knowledge
In acute reperfused MI, gadolinium enhancement of the myocardium in the first minutes 
after contrast administration is a novel CMR measure of the AAR that correlates well 
with established CMR measures and a histopathological defined size of the AAR.
Translational Outlook
This study demonstrates gadolinium enhancement of both reversible and irreversibly 
damaged myocardium in acute MI. Further study of the optimal timing of early 
gadolinium enhancement after contrast administration for AAR determination in clinical 
studies is warranted.
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Figure 1. Slice-by-slice comparison from one animal of early and late gadolinium enhancement 
compared to infarct by pathology
Short axis stack was aligned from base (left) to apex (right) for quantification of 
enhancement. The extent of EGE (upper row) exceeds that of LGE (middle row) and TTC 
(bottom row) in all slices. EGE= early gadolinium enhancement, LGE = late gadolinium 
enhancement, TTC = triphenyltetrazolium chloride.
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Figure 2. AAR and infarct measures by pathology and CMR
There was no difference in the size of AAR by microspheres compared to the size of EGE. 
EGE was greater than both CMR and pathological measures of infarction. EGE = early 
gadolinium enhancement, LGE= late gadolinium enhancement, TTC = triphenyltetrazolium 
chloride.
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Figure 3. Per-animal comparison of EGE and AAR by microspheres
The size of enhancement on EGE images correlated very well to the size of AAR by 
microsphere analysis (scatterplot, left), with minimal systematic bias on the Bland-Altman 
plot (right). Dotted lines represent line of identity in scatterplot and mean± 2SD in Bland-
Altman plot. AAR= area at risk, EGE = early gadolinium enhancement.
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Figure 4. Slice-by-slice comparison of EGE and AAR by microspheres
On a per-slice basis the correlation between EGE and pathological AAR (microsphere 
analysis) was very good (scatterplot, left). The bias by Bland-Altman (right) was only 3%. 
Data represents 68 slices from 11 animals. AAR= area at risk, EGE = early gadolinium 
enhancement.
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Figure 5. Comparison of EGE and CMR measures of AAR
The size of enhancement by EGE also correlated very well to the size of the AAR by both 
CMR measures of AAR. Data for comparisons was available from 10 animals. Dotted lines 
represent line of identity in scatterplot and mean± 2SD in Bland-Altman plot (right panels). 
AAR= area at risk, EGE = early gadolinium enhancement.
Hammer-Hansen et al. Page 16
JACC Cardiovasc Imaging. Author manuscript; available in PMC 2018 February 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Figure 6. Midventricular EGE, LGE and TTC slices from three representative animals
The transmural extent of EGE is clearly greater than the infarction by TTC or LGE. EGE = 
early gadolinium enhancement, LGE = late gadolinium enhancement, TTC = 
triphenyltetrazolium chloride.
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Figure 7. Comparison of AAR by CMR (native T1, native 2 and EGE) and infarct size by 
pathology
In all animals, the size of enhancement by CMR was greater than the size of infarct by TTC. 
Dotted lines link CMR data from the same animal. Native T1 data was only available for 10 
dogs and native T2 data was only available for 10 other dogs. The diagonal line indicates the 
line of identity. EGE = early gadolinium enhancement, TTC = triphenyltetrazolium chloride.
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Figure 8. Infarct size comparisons
The size of infarction by LGE showed excellent correlation to infarct size by pathology and 
minimal bias in the Bland-Altman plot (right). Dotted lines represent line of identity in 
scatterplot (left) and mean ± 2SD in Bland-Altman plot. LGE = late gadolinium 
enhancement, TTC = triphenyltetrazolium chloride.
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Figure 9. Pathology and CMR images of the same midventricular short axis slice
The AAR determined by abnormal microsphere blood flow during occlusion was not 
significantly different than the size of hyperenhancement on native T1 maps, native T2 
maps, or EGE. The size of enhancement by EGE 3 minutes after contrast administration was 
significantly greater than the size of enhancement by LGE and the pathological infarct size 
determined by TTC. EGE = early gadolinium enhancement, LGE = late gadolinium 
enhancement, TTC = triphenyltetrazolium chloride.
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